NYSEAMERICAN:STXS - Stereotaxis, Inc Stock Price & Analysis

About Stereotaxis, Inc (NYSEAMERICAN:STXS)

(NYSEAMERICAN:STXS) Stereotaxis, Inc. designs, manufactures, and markets robotic magnetic navigation (RMN) systems for use in hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease in the United States and internationally. Its RMN systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system that offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also provides Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane and full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides various disposable components V-Loop, V-Sono, and V-CAS devices; and V-CAS Deflect catheter advancement systems. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

STXS Stock Price

Statistics Highlights (NYSEAMERICAN:STXS)

Shares Outstanding	74.64M	Beta	1.63
Public Float	50.45M	P/E Ratio	-
% Short of Float	-	Dividend (Yield)	-
Held by Insiders	14.04%	Ex-Dividend Date
Held by Institutions	57.64%	IPO Date	Aug 12, 2004

Explore More on "Statistics" Section

STXS Financial Summary

|

	Dec 21	Dec 20	Dec 19
Revenue	$35.02M	$26.63M	$28.90M
EBITDA	$-10.73M	$-6.52M	$-4.47M
Net Income	$-10.72M	$-6.65M	$-4.59M
Total Assets	$60.98M	$55.46M	$43.58M
Total Cash	$38.74M	$43.94M	$30.18M
Total Debt	$6.65M	$4.45M	$4.34M

	Dec 21	Sep 21	Jun 21
Revenue	$8.24M	$9.11M	$9.05M
EBITDA	$-3.36M	$-4.59M	$-1.18M
Net Income	$-3.35M	$-4.62M	$-1.21M
Total Assets	$60.98M	$61.92M	$57.34M
Total Cash	$38.74M	$40.24M	$42.05M
Total Debt	$6.65M	$6.57M	$1.17M

STXS Stock Price History

Stereotaxis, Inc Annual Stock Price History

Year	Open	Close	Change
2021	$6.24	$3.67	-41.27%
2021	$5.06	$6.24	23.32%
2020	$5.17	$5.06	-2.13%

Stereotaxis, Inc Daily Stock Price History

Date	Open	High	Low	Close	Change	Volume
Jun 27, 2022	$1.99	$2.00	$1.91	$1.91	-13.96%	316.70K
Jun 8, 2022	$2.31	$2.33	$2.17	$2.22	16.84%	390.90K
Jun 14, 2022	$2.05	$2.05	$1.88	$1.90	-17.03%	506.70K

View More on "Price History" Section

(NYSEAMERICAN:STXS) Stock Price FAQs

What is today's stock price of Stereotaxis, Inc (NYSEAMERICAN:STXS)?

The current stock price of Stereotaxis, Inc (NYSEAMERICAN:STXS) is $3.67.
Today STXS stock price opened at $3.76 after previous close of $3.71.
During the day, Stereotaxis, Inc stock quote has varied from a low of $3.60 to a high of $3.78.

What is Stereotaxis, Inc's 52-week change?

STXS 52-week high stock quote is $10.30, which is 181.00% above the current share price.
The Stereotaxis, Inc (NYSEAMERICAN:STXS) 52-week low stock price is $2.95, which is 19.50% below the current share price.
Stereotaxis, Inc share price volatility (52-week beta) is 1.63.

Is Stereotaxis, Inc a buy?

According to 3 analysts, the current consensus recommendation for Stereotaxis, Inc stock is "Strong Buy" at an average rating score of 5.00 (out of 5).
There are currently 3 "Strong Buy", 0 "Buy", 0 "Hold", 0 "Sell", and 0 "Strong Sell" analysts recommendations for the STXS stock.
The 12 month average price target forecast for STXS stock is $10.83, representing a 195.60% increase from the current STXS stock price of $3.67.

Stereotaxis, Inc (NYSEAMERICAN:STXS) FAQ

How Much is Stereotaxis, inc Worth?

Stereotaxis, inc's worth today based on market capitalisation is $276.91M

How much dividend does Stereotaxis, inc Pay?

The current annualized dividend payout for STXS stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Stereotaxis, inc's "Dividend" Section

When is the next earnings date for Stereotaxis, inc (NYSEAMERICAN:STXS)?

Stereotaxis, inc is expected to report earnings on August 08 ,2022.
View More Details on Stereotaxis, inc's 'Earnings' Section

What is Stereotaxis, inc’s Price to Earning (PE) ratio?

STXS stock also has a Price to Sales (P/S) ratio of 7.91, a Price to Book of 8.03 and Price/Earnings to Growth (PEG) of 0.00.

What is the Stereotaxis, inc's ticker?

Stereotaxis, inc trades on the NYSE American stock market in USA under the ticker symbol "STXS". Stereotaxis, inc’s stock symbol can also be displayed as "NYSEAMERICAN:STXS".

When did STXS go public?

Stereotaxis, inc completed its initial public offering (IPO) on August 12 ,2004.

Who are the owners of Stereotaxis, inc?

Stereotaxis, inc (NYSEAMERICAN:STXS) is owned by 57.64% institutional shareholders and by 14.04% insiders. The rest is owned by the public.
Explore More Details on Stereotaxis, inc's “Ownership” Section

Who are the key executives of Stereotaxis, inc (STXS)?

Stereotaxis, inc's key executive team includes the following managers:

Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A., CFA, CPA, CEO & Chairman (1987)
Ms. Kimberly R. Peery, CFO & Sec. (NA)
John Platt, Sr. Director of Project Management & Systems Software (NA)
Nathan Kastelein, R&D Leader and Sr. Director of R&D and Advanced Concepts (NA)
Brian Kidd, R&D Leader and Sr. Director of Product Devel. (NA)
Mr. Guy Judkowski, Equity Portfolio Mang. (NA)

What is Stereotaxis, inc’s Sector & Industry Classification?

Stereotaxis, inc (NYSEAMERICAN:STXS) is classified under the "Healthcare" sector and under the "Medical Instruments & Supplies" industry.

How many employees work for Stereotaxis, inc?

Currently the number of employees working for Stereotaxis, inc is 130.

Where are Stereotaxis, inc's Headquarters?

Stereotaxis, inc (NYSEAMERICAN:STXS) is headquartered in MO, United States.

What are Stereotaxis, inc's Address and Phone Number?

Stereotaxis, inc’s mailing address is 710 North Tucker Boulevard, Saint Louis, MO, United States, 63101.
The company’s phone number is 314 678 6100.

What is the official website for Stereotaxis, inc?

Stereotaxis, inc’s official website is http://www.stereotaxis.com

Stereotaxis, Inc Stock (NYSEAMERICAN:STXS)